New CMS Alzheimer's drug coverage plan raises questions around worth
A Medicare plan for covering new Alzheimer's drugs treatments is reviving thorny questions about whether pricey treatments with modest success slowing the disease's progression are worth the cost and safety concerns.Driving the news: The Centers for Medicare and Medicaid Services on Thursday outlined conditions under which it would expand coverage for a specific class of…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Flood insurance rates spur lawsuit
Health insurance renewal scam targeting some New Yorkers
Advisor News
- Is a Roth IRA conversion key to strategic tax planning?
- Regulator group aims for reinsurance asset testing guideline by June
- Bessent confirmed as Treasury secretary
Former hedge fund guru to oversee Trump's tax cuts, deregulation and trade changes
- Jackson National study: vast underestimate of health care, LTC costs for retirement
- EDITORIAL: Home insurance, tax increases harm county’s housing options
More Advisor NewsAnnuity News
Health/Employee Benefits News
- Many died in sober living homes due to fumbled fraud response
- Let's talk about Long Term Care insurance
- Many died in sober living homes as Arizona officials fumbled Medicaid fraud response
- Peter Daniel: Government mandates are driving up healthcare costs in NC
- NC bill would limit insurers' prior authorizations
More Health/Employee Benefits NewsLife Insurance News
- Legals for January, 31 2025
- Automatic Shelf Registration Statement (Form S-3ASR)
- Best’s Special Report: Impairments in US Life/Health Insurance Industry Jump to 10 in 2023
- AM Best Maintains Under Review With Developing Implications Status for Credit Ratings of Solidarity Bahrain B.S.C.
- AM Best Maintains Under Review With Developing Implications Status for Credit Ratings of First Insurance Company
More Life Insurance News